• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Innate Pharma SA to Release FY2025 Q3 Earnings on November 13 Pre-Market EST, Forecast Revenue USD 2.324 M, EPS USD -0.142
00:24
Oct28
Innate Pharma SA Outlines Strategy and Pipeline for Next-Generation Antibody Cancer Therapies
12:13
Sep17
Innate Pharma SA released FY2025 Semi-Annual Earnings on September 17 Pre-Market EST, actual revenue USD 5.475 M (forecast USD 12.23 M), actual EPS USD -0.2816 (forecast USD -0.35)
13:30
Innate Pharma SA released FY2025 Q1 earnings on September 17 Pre-Market EST, actual revenue USD 2.63 M, actual EPS USD -0.1353
13:30
Innate Pharma SA released FY2025 Q2 earnings on September 17 Pre-Market (EST), actual revenue USD 2.844 M, actual EPS USD -0.1436
13:30
Sep9
Innate Pharma SA to Release FY2025 Semi-Annual Earnings on September 16, 2025 (EST), Forecast Revenue USD 12.27 M, EPS USD -0.35
00:10

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release

Sep17
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.844 M, Net Income -12.49 M, EPS -0.1463

May13
Earning Release(EST)

FY2025 Q1 Earning Release

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
20.080
+197.13%
+13.322
SMX
300.000
+112.77%
+159.000
WHLR
5.784
+78.52%
+2.550
GURE
8.051
+69.85%
+3.311
DBRG
14.490
+49.07%
+4.760
IRBT
4.345
+43.40%
+1.320
TORO
5.550
+34.38%
+1.420
TDIC
0.3691
+31.45%
+0.088
LICN
3.846
+31.26%
+0.916
PRAX
246.365
+29.69%
+56.395
View More